Report Scope & Overview:
The E-Pharmacy Market size was estimated USD 60.2 billion in 2022 and is expected to reach USD 272.9 billion by 2030 at a CAGR of 20.8% during the forecast period of 2023-2030.
An increase in tech-savvy consumers, improved digitalization of healthcare services, and increased internet penetration globally are the main factors propelling market expansion. The rise is also being fuelled by consumers who prioritise convenience and choose online shopping. The entire increase is anticipated to be fuelled by the healthcare sector's expanding usage of digital technologies and e-commerce. Venture capitalist Mark Cuban launched a digital pharmacy in January 2022 that provides more than 100 generic pharmaceuticals at a price that is entirely transparent. Chronically ill patients from nuclear families and patients who are unable to leave their homes benefit from the easier access offered by e-pharmacy. The industry is also predicted to grow as the number of seniors increases. A number of variables, such as convenience of use, increased digitalization, and an increase in Medicare enrollments, are contributing to the surge.
Increasing levels of Internet usage, convenient and reachable.
Expanding chronic conditions & technological progress.
E-pharmacy has become more popular as a result of increased global internet usage and accessibility, which allows customers to simply buy prescriptions online. E-pharmacies draw busy people and people with restricted mobility since they provide 24/7 accessibility, doorstep delivery, and ease when ordering drugs. Globally, the prevalence of chronic ailments including diabetes, heart disease, and respiratory problems has grown, which is fueling demand for medicines and expanding the e-pharmacy business.
Regulatory obstacles Access to healthcare is restricted by opposition to change.
Expansion of the product line Integration of telemedicine Strategic alliances ageing population expanding
Maintaining client confidence and Logistics for last-mile deliveries.
Cost and pricing competition, Data privacy and security.
The validity and quality of the drugs, the availability of secure payment methods, and the rapid resolution of client complaints are all ways that e-pharmacy businesses may establish and maintain consumer confidence. Successful last-mile distribution of drugs requires efficiency and promptness. It's crucial to address logistical issues, including coverage of rural areas and transportation congestion. Since there is a lot of rivalry in the e-pharmacy market, pricing methods must be carefully maintained to preserve profitability and stay competitive.
IMPACT OF RUSSIAN UKRAINE WAR
The supply chains for pharmaceutical items may be disrupted if the war intensifies and results in geopolitical tensions or trade restrictions. The availability of pharmaceuticals is strongly dependent on the efficiency of the supply chain for e-pharmacies. Any supply chain hiccups might cause delays or drug shortages, which would have an effect on the e-pharmacy sector. Governments may impose additional rules or limitations on international trade, including pharmaceutical items, during periods of geopolitical unrest. The operations of E-Pharmacy businesses may be impacted by these regulatory developments, especially those that depend on overseas sourcing and delivery. E-pharmacies may have difficulties adhering to new laws and reacting to requirements that change.
Healthcare systems, including hospitals and traditional brick-and-mortar pharmacies, can be severely strained during armed situations. E-Pharmacy may be quite helpful in such circumstances in ensuring the continuity of pharmaceutical supply and healthcare services. People may turn to e-Pharmacy platforms more frequently as they look for alternatives to traditional pharmacies that are harmed by the conflict. The digital infrastructure needed for E-Pharmacy operations may be impacted if the war damages communication networks or infrastructure.
IMPACT OF ONGOING RECESSION
Recessions can prompt individuals to change their consumption patterns and seek more value-driven options. E-Pharmacy platforms that offer competitive pricing, generic alternatives, and loyalty programs may attract consumers looking to stretch their healthcare budget. E-Pharmacy companies that can effectively communicate their value proposition and cost-saving advantages may experience increased market share. Potential decrease in non-essential purchases during a recession, consumers may prioritize essential medications and reduce spending on non-urgent healthcare items, such as over-the-counter products and supplements. E-Pharmacy platforms that heavily rely on sales of non-essential healthcare items may face challenges in maintaining revenue levels.
By Drug type
Over-the-counter drug (OTC)
Rest of Eastern Europe
Rest of Western Europe
Rest of Asia Pacific
Middle East & Africa
Rest of Middle East
Rest of Africa
Rest of Latin America
In 2022, North America held the largest market share. A few of the key factors influencing the expansion of the regional market are the rising acceptance of e-commerce, the rising elderly population, rising online sales, expanded healthcare infrastructure, and a favourable attitude towards the adoption of new technologies. Additionally, ePharmacy and the growing tendency towards the direct-to-patient model of Americans. A sizeable portion of the worldwide online pharmacy market is located in Europe. Due to the expanding elderly population, rising incidence of chronic illnesses, quick e-commerce expansion, and well-developed IT infrastructures, the e-Pharmacy market in Europe is predicted to grow throughout the projected period.
The region with the fastest CAGR is expected to be Asia-Pacific throughout the forecast period. Emerging economies like China and India have significant potential for growth because of their massive populations and rising government initiatives promoting the use of digital technologies. Because more public and private companies are taking strategic initiatives, it is anticipated that the market in Asia Pacific will grow faster in the next few years.
The major key players are Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Inc., Express Scripts Holding Company, CVS Health, Optum Rx, Inc., Rowlands Pharmacy, DocMorris (Zur Rose Group AG), Cigna Corporation (Express Scripts Holdings), Amazon.com Inc., Axelia Solutions (Pharmeasy), Apex Healthcare Berhad (Apex Pharmacy), Apollo Pharmacy, Netmeds and others.
Walgreen Co-Company Financial Analysis
Amazon: Amazon announced its intention to start selling prescription drugs online in Japan in September 2022. It aims to collaborate with small and medium-sized pharmacies to offer a platform where users may receive online medicine administration instructions. Customers might have their medications delivered to their homes without going to a drugstore.
Walmart, Inc: Walmart Canada and Canada Health Infoway partnered in September 2022. 14 Walmart Canada pharmacies in Ontario, Alberta, Saskatchewan, and New Brunswick now have access to Infoway's PrescribeIT electronic prescription service, with plans to add more sites by the end of the year.
|Market Size in 2022||US$ 60.2 Bn|
|Market Size by 2030||US$ 272.9 Bn|
|CAGR||CAGR of 20.8 % From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Drug type (Prescription drug, Over-the-counter drug)|
|Regional Analysis/Coverage||North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)|
|Company Profiles||Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Inc., Express Scripts Holding Company, CVS Health, Optum Rx, Inc., Rowlands Pharmacy, DocMorris (Zur Rose Group AG), Cigna Corporation (Express Scripts Holdings), Amazon.com Inc., Axelia Solutions (Pharmeasy), Apex Healthcare Berhad (Apex Pharmacy), Apollo Pharmacy, Netmeds|
|Key Drivers||• Increasing levels of Internet usage, convenient and reachable.
• Expanding chronic conditions & technological progress.
|Market Restraints||• Regulatory obstacles Access to healthcare is restricted by opposition to change.|
Ans: The CAGR Growth rate of E-Pharmacy Market is approx. CAGR 20.8% over the forecast.
Ans: The projected size of E-Pharmacy Market was estimated USD 60.2 billion in 2022 and is expected to reach USD 272.9 billion by 2030.
Ans: The major key players are The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Inc., Express Scripts Holding Company, CVS Health, Optum Rx, Inc., Rowlands Pharmacy, DocMorris (Zur Rose Group AG), Cigna Corporation (Express Scripts Holdings), Amazon.com Inc., Axelia Solutions (Pharmeasy), Apex Healthcare Berhad (Apex Pharmacy), Apollo Pharmacy, Netmeds and others.
Ans: In 2021, North America will have the largest share.
Ans: Between 2022 and 2030, Asia-Pacific will see the greatest CAGR growth.
TABLE OF CONTENT
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4 Impact of Russia-Ukraine war
4.2 Impact of Ongoing Recession
4.2.2 Impact on major economies
22.214.171.124 United Kingdom
126.96.36.199 South Korea
188.8.131.52 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8.E-Pharmacy Market Segmentation, By Drug Type
8.1 Prescription drug
8.2 Over-the-counter drug (OTC)
9. Regional Analysis
9.2 North America
9.2.1 North America E-Pharmacy Market by Country
9.2.2 North America E-Pharmacy Market by Drug Typ
184.108.40.206 USA E-Pharmacy Market by Drug Type
220.127.116.11 Canada E-Pharmacy Market by Drug Type
18.104.22.168 Mexico E-Pharmacy Market by Raw Technology
9.3.1 Eastern Europe
22.214.171.124 Eastern Europe E-Pharmacy Market by Country
126.96.36.199 Eastern Europe E-Pharmacy Market by Drug Type
188.8.131.52.1 Poland E-Pharmacy Market by Drug Type
184.108.40.206.1 Romania E-Pharmacy Market by Drug Type
220.127.116.11.1 Hungary E-Pharmacy Market by Drug Type
18.104.22.168.1 Turkey E-Pharmacy Market by Drug Type
22.214.171.124 Rest of Eastern Europe
126.96.36.199.1 Rest of Eastern Europe E-Pharmacy Market by Drug Type
9.3.2 Western Europe
188.8.131.52 Western Europe E-Pharmacy Market by Country
184.108.40.206 Western Europe E-Pharmacy Market by Drug Type
220.127.116.11.1 Germany E-Pharmacy Market by Drug Type
18.104.22.168.1 France E-Pharmacy Market by Drug Type
22.214.171.124.1 UK E-Pharmacy Market by Drug Type
126.96.36.199.1 Italy E-Pharmacy Market by Drug Type
188.8.131.52.1 Spain E-Pharmacy Market by Drug Type
184.108.40.206.1 Netherlands E-Pharmacy Market by Drug Type
220.127.116.11.1 Switzerland E-Pharmacy Market by Drug Type
18.104.22.168.1 Austria E-Pharmacy Market by Drug Type
22.214.171.124 Rest of Western Europe
126.96.36.199.1 Rest of Western Europe E-Pharmacy Market by Drug Type
9.4.1 Asia Pacific E-Pharmacy Market by Country
9.4.2 Asia Pacific E-Pharmacy Market by Drug Type
188.8.131.52 China E-Pharmacy Market by Drug Type
184.108.40.206 India E-Pharmacy Market by Drug Type
220.127.116.11 Japan E-Pharmacy Market by Drug Type
9.4.6 South Korea
18.104.22.168 South Korea E-Pharmacy Market by Drug Type
22.214.171.124 Vietnam E-Pharmacy Market by Drug Type
126.96.36.199 Singapore E-Pharmacy Market by Drug Type
188.8.131.52 Australia E-Pharmacy Market by Drug Type
9.4.10 Rest of Asia-Pacific
184.108.40.206 Rest of Asia-Pacific E-Pharmacy Market by Drug Type
9.5 Middle East & Africa
9.5.1 Middle East
220.127.116.11 Middle East E-Pharmacy Market by Country
18.104.22.168 Middle East E-Pharmacy Market by Drug Type
22.214.171.124.1 UAE E-Pharmacy Market by Drug Type
126.96.36.199.1 Egypt E-Pharmacy Market by Drug Type
188.8.131.52 Saudi Arabia
184.108.40.206.1 Saudi Arabia E-Pharmacy Market by Drug Type
220.127.116.11.1 Qatar E-Pharmacy Market by Drug Type
18.104.22.168 Rest of Middle East
22.214.171.124.1 Rest of Middle East E-Pharmacy Market by Drug Type
126.96.36.199 Africa E-Pharmacy Market by Country
188.8.131.52 Africa E-Pharmacy Market by Drug Type
184.108.40.206.1 Nigeria E-Pharmacy Market by Drug Type
220.127.116.11 South Africa
18.104.22.168.1 South Africa E-Pharmacy Market by Drug Type
22.214.171.124 Rest of Africa
126.96.36.199.1 Rest of Africa E-Pharmacy Market by Drug Type
9.6 Latin America
9.6.1 Latin America E-Pharmacy Market by Country
9.6.2 Latin America E-Pharmacy Market by Drug Type
188.8.131.52 Brazil E-Pharmacy Market by Drug Type
184.108.40.206 Argentina E-Pharmacy Market by Drug Type
220.127.116.11 Colombia E-Pharmacy Market by Drug Type
9.6.6 Rest of Latin America
18.104.22.168 Rest of Latin America E-Pharmacy Market by Drug Type
10 Company Profile
10.1 Kroger Co.
10.1.1 Company Overview
10.1.4 SWOT Analysis
10.1.5 The SNS View
10.2 Walgreen Co.
10.2.1 Company Overview
10.2.4 SWOT Analysis
10.2.5 The SNS View
10.3 Giant Eagle, Inc.
10.3.1 Company Overview
10.3.4 SWOT Analysis
10.3.5 The SNS View
10.4 Walmart, Inc.
10.4 Company Overview
10.4.4 SWOT Analysis
10.4.5 The SNS View
10.5 Express Scripts Holding Company.
10.5.1 Company Overview
10.5.4 SWOT Analysis
10.5.5 The SNS View
10.6 CVS Health.
10.6.1 Company Overview
10.6.4 SWOT Analysis
10.6.5 The SNS View
10.7 Optum Rx, Inc.
10.7.1 Company Overview
10.7.4 SWOT Analysis
10.7.5 The SNS View
10.8 Rowlands Pharmacy.
10.8.1 Company Overview
10.8.4 SWOT Analysis
10.8.5 The SNS View
10.9 DocMorris (Zur Rose Group AG).
10.9.1 Company Overview
10.9.3 Product/Services /Offerings
10.9.4 SWOT Analysis
10.9.5 The SNS View
10.10 Amazon.com Inc.
10.10.1 Company Overview
10.10.4 SWOT Analysis
10.10.5 The SNS View
11. Competitive Landscape
11.1 Competitive Bench marking
11.2 Market Share Analysis
11.3 Recent Developments
11.3.1 Industry News
11.3.2 Company News
11.3.3 Mergers & Acquisitions
12. USE Cases and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Blood Group Typing Market was estimated at USD 1.98 billion in 2022 and is poised to reach at 4.18 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 9.8% for the forecast period of 2023-2030.
The Artificial Tears Market size was USD 4802.22 Million in 2022 and is expected to Reach USD 7176.55 Million by 2030 and grow at a CAGR of 5.15% over the forecast period of 2023-2030.
The Heparin Market was estimated at USD 7.5 billion in 2022 and is poised to reach at 9.20 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 2.6% for the forecast period of 2023-2030.
The Psoriatic Arthritis Treatment Market size was USD 8.51 Billion in 2022 and is expected to Reach USD 17.33 Billion by 2030 and grow at a CAGR of 9.3% over the forecast period of 2023-2030.
The Portable Ultrasound Market size was USD 2355.85 Million in 2022 and is expected to Reach USD 6442.46 Million by 2030 and grow at a CAGR of 13.4 % over the forecast period of 2023-2030.
The Cardiovascular Information System Market Size was valued at USD 8.20 billion in 2022 and is expected to reach USD 14.96 billion by 2030, and grow at a CAGR of 7.8% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone